Yalei Wen

437 total citations
16 papers, 283 citations indexed

About

Yalei Wen is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Yalei Wen has authored 16 papers receiving a total of 283 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Oncology and 2 papers in Cell Biology. Recurrent topics in Yalei Wen's work include Ubiquitin and proteasome pathways (8 papers), Histone Deacetylase Inhibitors Research (4 papers) and Protein Degradation and Inhibitors (4 papers). Yalei Wen is often cited by papers focused on Ubiquitin and proteasome pathways (8 papers), Histone Deacetylase Inhibitors Research (4 papers) and Protein Degradation and Inhibitors (4 papers). Yalei Wen collaborates with scholars based in China, Thailand and United States. Yalei Wen's co-authors include Tongzheng Liu, Caishi Zhang, Mei Li, Ying‐Jie Zhu, Yuchen Gao, Hui Tang, Xiao Yang, Hongyan Yang, Xiaoyun Lu and Chaofan Wang and has published in prestigious journals such as Journal of the American Chemical Society, Nature Communications and Cell Death and Differentiation.

In The Last Decade

Yalei Wen

16 papers receiving 281 citations

Peers

Yalei Wen

ONCOL

IMMUN

PRM

Hongyin Sun China

Ludmila de Faro Valverde Brazil

Dimitris C. Kanellis Denmark

Nico Hinz Germany

Jamie Z. Roberts United Kingdom

Keerthi Kurma France

Huiling Zhou China

Linda Tran United States

Gatha Thacker India

Hongyin Sun China

Yalei Wen

180 ×1.1

79 ×0.8

ONCOL

36 ×0.9

70 ×1.8

IMMUN

22 ×0.7

PRM

Citations per year, relative to Yalei Wen Yalei Wen (= 1×) peers Hongyin Sun

Countries citing papers authored by Yalei Wen

Since Specialization

Citations

This map shows the geographic impact of Yalei Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yalei Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yalei Wen more than expected).

Fields of papers citing papers by Yalei Wen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yalei Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yalei Wen. The network helps show where Yalei Wen may publish in the future.

Co-authorship network of co-authors of Yalei Wen

This figure shows the co-authorship network connecting the top 25 collaborators of Yalei Wen. A scholar is included among the top collaborators of Yalei Wen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yalei Wen. Yalei Wen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Wen, Yalei, Xiao Yang, Shengrong Li, et al.. (2025). Targeting CDK4/6 suppresses colorectal cancer by destabilizing YAP1. MedComm. 6(3). e70103–e70103. 2 indexed citations

Li, Mei, Lei Huang, Jiayi Chen, et al.. (2025). AMPK-activated BAP1 regulates pVHL stability and tumor-suppressive functions. Cell Death and Differentiation. 1 indexed citations

Huang, Lei, Yalei Wen, Qin Guo, et al.. (2025). CK2α-mediated phosphorylation of DUB3 promotes YAP1 stability and oncogenic functions. Cell Death and Disease. 16(1). 27–27. 2 indexed citations

He, Xiaoqiang, S. Zeng, Yalei Wen, et al.. (2025). Covalent Recruitment of NEDD4 for Targeted Protein Degradation: Rational Design of Small Molecular Degraders. Journal of the American Chemical Society. 147(25). 21512–21525. 3 indexed citations

Wen, Yalei, Hui Wang, Xiao Yang, et al.. (2024). Pharmacological targeting of casein kinase 1δ suppresses oncogenic NRAS-driven melanoma. Nature Communications. 15(1). 10088–10088. 3 indexed citations

Peng, Liang, Jing Guo, Peng Chen, et al.. (2024). A Self-Assembled Nano-Molecular Glue (Nano-mGlu) Enables GSH/H₂O₂-Triggered Targeted Protein Degradation in Cancer Therapy. Journal of the American Chemical Society. 147(1). 372–383. 6 indexed citations

Li, Mei, Litao Zhang, Lei Huang, et al.. (2024). Energy stress-activated AMPK phosphorylates Snail1 and suppresses its stability and oncogenic function. Cancer Letters. 595. 216987–216987. 6 indexed citations

Fan, Yu, Jincai Wang, Jingyi Jian, et al.. (2024). High-throughput discovery of highly selective reversible hMAO-B inhibitors based on at-line nanofractionation. Acta Pharmaceutica Sinica B. 14(4). 1772–1786. 10 indexed citations

Wan, Rui, et al.. (2023). Deubiquitinating enzyme OTUD4 regulates metastasis in triple-negative breast cancer by stabilizing Snail1. Experimental Cell Research. 434(1). 113864–113864. 2 indexed citations

10.

Li, Mei, Jiayi Chen, Jiaxin Tang, et al.. (2023). Phosphorylation of USP29 by CDK1 Governs TWIST1 Stability and Oncogenic Functions. Advanced Science. 10(11). e2205873–e2205873. 31 indexed citations

11.

Gao, Yuchen, Jiaxin Tang, Caishi Zhang, et al.. (2023). OTUD4 regulates metastasis and chemoresistance in melanoma by stabilizing Snail1. Journal of Cellular Physiology. 238(11). 2546–2555. 7 indexed citations

12.

Chen, Jiayi, Mei Li, Yeqing Liu, et al.. (2023). PIN1 and CDK1 cooperatively govern pVHL stability and suppressive functions. Cell Death and Differentiation. 30(4). 1082–1095. 9 indexed citations

13.

Wen, Yalei, Ying‐Jie Zhu, Caishi Zhang, et al.. (2022). Chronic inflammation, cancer development and immunotherapy. Frontiers in Pharmacology. 13. 1040163–1040163. 109 indexed citations

14.

Yang, Fang, Yalei Wen, Chaofan Wang, et al.. (2022). Efficient targeted oncogenic KRASG12C degradation via first reversible-covalent PROTAC. European Journal of Medicinal Chemistry. 230. 114088–114088. 73 indexed citations

15.

Ding, Liang, Yalei Wen, Xin Zhang, et al.. (2021). Transcriptional network constituted of CBP, Ku70, NOX2, and BAX prevents the cell death of necrosis, paraptosis, and apoptosis in human melanoma. Cell Death Discovery. 7(1). 40–40. 9 indexed citations

16.

Ding, Liang, Rui Jiang, Keya Zhou, et al.. (2020). Design, Synthesis and Characterization of a Novel Type of Thermo-Responsible Phospholipid Microcapsule–Alginate Composite Hydrogel for Drug Delivery. Molecules. 25(3). 694–694. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact